Publications Category: Technology Platform
Harnessing Human Papillomavirus’ Natural Tropism to Target Tumors
Virus-like particle-drug conjugates induce protective, long-lasting adaptive anti-tumor immunity in the absence of specifically targeted tumor antigens
Unraveling Heparan Sulfate Proteoglycan Binding Motif for Cancer Cell Selectivity
Frontiers in Oncology | Brunetti, et al.
An infrared dye-conjugated virus-like particle for the treatment of primary uveal melanoma
Molecular Cancer Therapeutics | Kines, et al.
Immunogenic Human Papillomavirus Pseudovirus-Mediated Suicide-Gene Therapy for Bladder Cancer
International Journal of Molecular Sciences | Hojeij, et al.
Human papillomavirus capsids preferentially bind and infect tumor cells
International Journal of Cancer | Kines, et al.
Heparan sulfate signaling in cancer
Trends in Biochemical Sciences | Knelson, et al.
Ovarian cancer gene therapy using HPV-16 pseudovirion carrying the HSV-tk gene
Ma, et al.
The sweet and sour of cancer: glycans as novel therapeutic targets
Nature Reviews Cancer, 2005 | Fuster, et al.